Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-Diagnosis
Open Access
Abstract
Background/Objectives: Individuals with type 2 diabetes have an increased risk of pancreatic cancer (PC), yet early detection markers remain limited. We examined associations between routinely measured serum biomarkers and subsequent PC risk in this population. Methods: Using the Swedish AMORIS cohort, 101,051 individuals aged ≥50 years at diabetes diagnosis with newly diagnosed type 2 diabetes (1969–2019) were analysed. Ten biomarkers, including liver enzymes, inflammatory markers, renal function, and lipid profiles, were assessed. The primary analysis focused on measurements within ±1 year of the diabetes diagnosis (n = 13,190; Cohort 1). Sensitivity analyses considered broader windows: −3, −5, and −10 years before diagnosis to +1 year after, and from the diagnosis to the end of the follow-up (Cohorts 2–5). Multivariable Cox models adjusted for age and sex were applied. Results: During a mean follow-up of 15.9 years, 192 individuals developed PC. In primary analysis, higher alkaline phosphatase was associated with increased PC risk (HR: 1.16, 95% CI: 1.09–1.24 per 1 SD increase). Higher creatinine was associated with reduced PC risk (HR: 0.55, 95% CI: 0.36–0.83 per 1 SD increase), while haptoglobin (HR: 1.20, 95% CI: 0.97–1.49 per 1 SD increase) suggested a modest positive association. Patterns were consistent across sensitivity analyses. Conclusions: In individuals ≥ 50 years with newly diagnosed type 2 diabetes, higher ALP and lower creatinine were independently associated with increased PC risk before and after diabetes diagnosis, while haptoglobin showed a modest positive association. As these biomarkers are routine laboratory panels, their potential to support risk stratification in primary care requires further evaluation within established risk-prediction frameworks.Keywords
Funding Information
- Pancreatic Cancer UK
- Pancreatic Cancer UK (EDDISA-May21_100002)
This publication has 32 references indexed in Scilit:
- Diagnostic Approach to Abnormal Alkaline Phosphatase ValueMayo Clinic Proceedings, 2025
- Metabolic dysfunction-associated steatotic liver disease and its link to cancerMetabolism, 2024
- Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohortJournal of Cachexia, Sarcopenia and Muscle, 2024
- Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization studyThe Lancet Regional Health - Western Pacific, 2022
- Early detection of pancreatic cancerThe Lancet Gastroenterology & Hepatology, 2020
- Early Detection of Pancreatic Cancer: Opportunities and ChallengesGastroenterology, 2019
- A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset DiabetesGastroenterology, 2017
- Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta‐analysis of 22 cohort studiesInternational Journal of Cancer, 2017
- Cohort Profile: The AMORIS cohortInternational Journal of Epidemiology, 2017
- Checking the Cox model with cumulative sums of martingale-based residualsBiometrika, 1993